[gentle music] Margaret Alexander: Good evening, everyone, and welcome to our Crossroads of Ideas, Gut Instincts: Microbes, Addiction, and Immunity, part one in our microbiome miniseries. I am Dr. Margaret Alexander. I am an assistant professor here at UW- …

(The Center Square) – A Pennsylvania ICU nurse has won a major legal victory in a rare case involving COVID-19 vaccine mandates and their intersection with workers’ compensation law. Kathleen Fee was injured on the job and later fired after her requests …

… injuries, autoimmune diseases, multiple sclerosis, vasculitis and vaccine … associated with multiple sclerosis, while involvement … vaccine; VAPP, vaccine-associated paralytic poliomyelitis; … circulating vaccine-derived poliovirus; iVDPV, vaccine-associated …

… advances in multiple sclerosis treatment drugs @ Multiple Sclerosis Competitive Report Multiple Sclerosis Overview Multiple sclerosis is … Nucleome Therapeutics, Vaccinex Inc., among others. Multiple Sclerosis Market Multiple Sclerosis Market Insights, …

… advances in multiple sclerosis treatment drugs @ Multiple Sclerosis Competitive Report Multiple Sclerosis Overview Multiple sclerosis is … Nucleome Therapeutics, Vaccinex Inc.,  among others. Multiple Sclerosis Market Multiple Sclerosis Market Insights, …

… as type 1 diabetes and multiple sclerosis, he said. “It has potential … , then chair of the anti-vaccine organization Children’s Health Defense … have been targeted by anti-vaccine activists. In January, Trump hosted …

… for individuals with multiple sclerosis (MS), especially … as myocarditis, pericarditis, vaccine-induced thrombotic thrombocytopenia, … -2 vaccines and multiple sclerosis: an update. … 2. Multiple sclerosis and COVID-19. National Multiple Sclerosis Society. …

… heavy fire from the anti-vaccine movement, including from health secretary … it start? Two studies on multiple sclerosis, an autoimmune disorder that attacks …

(MENAFN- GetNews) DelveInsight's, “Multiple sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including …

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of …